Today: 27 December 2025
Subscribe
Browse Category

Stock Market News 6 November 2025

Cummins (CMI) Q3 2025: Revenue $8.32B, Adjusted EPS $5.59; Dividend Lifted to $2.00 as Data‑Center Power Drives Beat and Accelera Faces Strategic Review

Cummins (CMI) Q3 2025: Revenue $8.32B, Adjusted EPS $5.59; Dividend Lifted to $2.00 as Data‑Center Power Drives Beat and Accelera Faces Strategic Review

Cummins Inc. (NYSE: CMI) delivered a stronger‑than‑expected third quarter, powered by surging demand for data‑center backup generation and solid service activity, even as North American truck markets softened. The company also raised its quarterly dividend and said it is conducting
6 November 2025
 ·  ·  ·  ·  · 
Krispy Kreme (DNUT) Q3 2025: Adjusted EPS Turns Positive, Free Cash Flow Returns as Turnaround Gains Traction — Nov. 6, 2025

Krispy Kreme (DNUT) Q3 2025: Adjusted EPS Turns Positive, Free Cash Flow Returns as Turnaround Gains Traction — Nov. 6, 2025

Krispy Kreme, Inc. (NASDAQ: DNUT) reported third‑quarter 2025 results before the bell, showing early progress on its turnaround: revenue softened year over year, but margins, cash generation and adjusted profitability improved. Shares jumped in early trading after the company posted
6 November 2025
 ·  ·  ·  ·  · 
Strive Asset Management (ASST) prices upsized 12% preferred stock IPO to raise ~$160M; fresh Semler (SMLR) merger filing lands — Nov. 6, 2025

Strive Asset Management (ASST) prices upsized 12% preferred stock IPO to raise ~$160M; fresh Semler (SMLR) merger filing lands — Nov. 6, 2025

Strive, Inc. (Nasdaq: ASST)—the parent of Strive Asset Management, LLC—priced an upsized initial public offering of its Variable Rate Series A Perpetual Preferred Stock (“SATA Stock”) at $80 per share, expanding the deal to 2,000,000 shares for ~$160 million in
6 November 2025
 ·  ·  ·  ·  ·  · 
Vistra (VST) Q3 2025: $652M Profit, 2026 EBITDA Outlook Raised to $6.8–$7.6B; Board Adds $1B Buyback

Vistra (VST) Q3 2025: $652M Profit, 2026 EBITDA Outlook Raised to $6.8–$7.6B; Board Adds $1B Buyback

What Vistra reported today Vistra posted third‑quarter 2025 GAAP net income of $652 million and Ongoing Operations Adjusted EBITDA of $1.581 billion. Management said the year‑over‑year decline in GAAP profit primarily reflects lower unrealized mark‑to‑market gains on hedging positions and
6 November 2025
 ·  ·  ·  ·  · 
BIYA Soars Over 100% on November 6, 2025: Baiya International’s Volatile Rally, Massive Volume, and What to Watch Ahead of 25‑for‑1 Share Consolidation Vote

BIYA Soars Over 100% on November 6, 2025: Baiya International’s Volatile Rally, Massive Volume, and What to Watch Ahead of 25‑for‑1 Share Consolidation Vote

What happened today (Nov. 6, 2025) Bottom line: It’s a trader‑driven move fueled by momentum, volume, and attention on micro‑cap gainers; no new company‑specific press release or SEC filing hit the tape this morning to explain the surge. (We checked
6 November 2025
 ·  ·  ·  ·  · 
Stagwell (STGW) Soars After Q3 Beat and Palantir AI Partnership; 2025 Outlook Calls for ~8% Net Revenue Growth (Nov. 6, 2025)

Stagwell (STGW) Soars After Q3 Beat and Palantir AI Partnership; 2025 Outlook Calls for ~8% Net Revenue Growth (Nov. 6, 2025)

What’s new today Earnings: Stagwell Inc. (NASDAQ: STGW) reported third‑quarter revenue of $743 million, GAAP EPS of $0.09, and adjusted EPS of $0.24. Management highlighted double‑digit “ex‑advocacy” momentum, with net revenue ex‑advocacy up 10% to $578 million, and adjusted EBITDA
6 November 2025
 ·  ·  ·  ·  ·  · 
Iovance Biotherapeutics (IOVA) Q3 2025: Revenue Climbs ~13% to ~$68M; Gross Margin Hits 43%, Guidance Reaffirmed — November 6, 2025

Iovance Biotherapeutics (IOVA) Q3 2025: Revenue Climbs ~13% to ~$68M; Gross Margin Hits 43%, Guidance Reaffirmed — November 6, 2025

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) reported third‑quarter 2025 results this morning (Nov. 6), highlighting sequential revenue growth, materially higher gross margins, and steady commercial momentum for its tumor‑infiltrating lymphocyte (TIL) therapy Amtagvi. Management also reaffirmed full‑year revenue guidance and flagged
6 November 2025
 ·  ·  ·  ·  · 
Novavax (NVAX) Raises 2025 Revenue Outlook After Q3 Beat; Sanofi Milestones Drive Guidance — November 6, 2025

Novavax (NVAX) Raises 2025 Revenue Outlook After Q3 Beat; Sanofi Milestones Drive Guidance — November 6, 2025

What happened today Novavax, Inc. (NASDAQ: NVAX) reported Q3 2025 results and raised its full‑year adjusted revenue framework to $1.04–$1.06 billion (from $1.00–$1.05 billion). Management cited momentum from licensing, supply, and milestone revenue—while excluding Sanofi‑led sales and royalties from the
6 November 2025
 ·  ·  ·  · 
AppLovin (APP) soars ~7% after blowout Q3 2025: revenue up 68%, buyback boosted by $3.2B, and Wedbush lifts price target to $800

AppLovin (APP) soars ~7% after blowout Q3 2025: revenue up 68%, buyback boosted by $3.2B, and Wedbush lifts price target to $800

AppLovin Corporation (NASDAQ: APP) is rallying today after reporting another set of blockbuster results and raising its buyback firepower. Shares were up roughly 7%–8% in Thursday trading as investors digested the company’s stronger‑than‑expected Q3 print and upbeat Q4 outlook, while
6 November 2025
 ·  ·  ·  ·  · 
D‑Wave Quantum (QBTS) Q3 2025: Revenue Doubles to $3.7M, Record $836M Cash, Bookings Accelerate — What It Means for the Stock Today

D‑Wave Quantum (QBTS) Q3 2025: Revenue Doubles to $3.7M, Record $836M Cash, Bookings Accelerate — What It Means for the Stock Today

D‑Wave Quantum Inc. (NYSE: QBTS) reported third‑quarter fiscal 2025 results before the open today, delivering 100% year‑over‑year revenue growth to $3.7 million and a sharp sequential uptick in customer bookings to $2.4 million. Shares were recently around $31 intraday, modestly
6 November 2025
 ·  ·  ·  ·  · 
Arm Holdings (ARM) Beats Q2, Lifts Q3 Outlook on AI Momentum — What to Know Today (Nov. 6, 2025)

Arm Holdings (ARM) Beats Q2, Lifts Q3 Outlook on AI Momentum — What to Know Today (Nov. 6, 2025)

Why Arm is rallying today Arm delivered another “beat‑and‑raise” quarter as AI workloads continue to shift toward Arm’s power‑efficient compute. Revenue of $1.14B (+34% YoY) topped expectations, while non‑GAAP EPS of $0.39 cleared the Street. Management guided Q3 well above
6 November 2025
 ·  ·  ·  ·  · 
1 … 737 738 739 740 741 … 917
Go toTop